跳至主要内容
临床试验/IRCT20211212053368N1
IRCT20211212053368N1招募中未知

The comparison of transforming growth factor beta-1 serum levels in early-stage breast cancer patients treated with external beam whole breast irradiation plus boost versus interstitial brachytherapy accelerated partial breast irradiation

Ahvaz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 no limit(—)
性别
Female

入选标准

  • Age more than 45 years
  • Unifocal and unicenric breast cancer less than or equal to 3 cm in size (including various histologies of invasive ductal, Papillary, mucinous, tubular, edullary and lobular carcinoma and low to moderate risk intraductal carcinoma)
  • No invasion to the lymphovascular space
  • No lymphatic involvement in invasive histologies
  • No distant metastasis
  • Consent to participate in the study

排除标准

  • Extensive Intraductal Component (EIC) in breast imaging evaluation
  • Paget disease of the breast or skin involvement
  • Synchronous tumor or history of breast cancer
  • History of malignancy 5 years before enrollment
  • Pregnancy or lactation
  • History of collagen vascular disease, or genetic diseases such as ataxia Telangiectasia that leads to increased radiation sensitivity

研究者

相似试验

TGFB-1 level in breast cancer patients treated with... | 临床试验